Short-course, oral flubendazole does not mediate significant efficacy against Onchocerca adult male worms or Brugia microfilariae in murine infection models

The Onchocerca ochengi adult implant and Brugia malayi microfilariemic Severe-Combined Immunodeficient (SCID) mouse models are validated screens to measure macrofilaricidal and microfilaricidal activities of candidate onchocerciasis drugs. The purpose of this study was to assess whether 5 daily sub-...

Full description

Bibliographic Details
Main Authors: Sjoberg, HT, Pionnier, N, Aljayyoussi, G, Metuge, HM, Njouendou, AJ, Chunda, VC, Fombad, FF, Tayong, DB, Gandjui, NVT, Akumtoh, DN, Chounna, PWN, Ndzeshang, BL, Lachaud, S, Tekle, F, Quirynen, L, Engelen, M, Baeten, B, Steven, A, Ward, SA, Taylor, MJ, Wanji, S, Turner, JD
Format: Journal article
Language:English
Published: Public Library of Science 2019
_version_ 1826279464550531072
author Sjoberg, HT
Pionnier, N
Aljayyoussi, G
Metuge, HM
Njouendou, AJ
Chunda, VC
Fombad, FF
Tayong, DB
Gandjui, NVT
Akumtoh, DN
Chounna, PWN
Ndzeshang, BL
Lachaud, S
Tekle, F
Quirynen, L
Engelen, M
Baeten, B
Steven, A
Ward, SA
Taylor, MJ
Wanji, S
Turner, JD
author_facet Sjoberg, HT
Pionnier, N
Aljayyoussi, G
Metuge, HM
Njouendou, AJ
Chunda, VC
Fombad, FF
Tayong, DB
Gandjui, NVT
Akumtoh, DN
Chounna, PWN
Ndzeshang, BL
Lachaud, S
Tekle, F
Quirynen, L
Engelen, M
Baeten, B
Steven, A
Ward, SA
Taylor, MJ
Wanji, S
Turner, JD
author_sort Sjoberg, HT
collection OXFORD
description The Onchocerca ochengi adult implant and Brugia malayi microfilariemic Severe-Combined Immunodeficient (SCID) mouse models are validated screens to measure macrofilaricidal and microfilaricidal activities of candidate onchocerciasis drugs. The purpose of this study was to assess whether 5 daily sub-cutaneous (s.c.) injections of standard flubendazole (FBZ) suspension (10mg/kg), a single s.c. injection (10mg/kg) or 5 daily repeated oral doses of FBZ amorphous solid dispersion (ASD) formulation (0.2, 1.5 or 15mg/kg) mediated macrofilaricidal efficacy against O. ochengi male worms implanted into SCID mice. The direct microfilaricidal activity against circulating B. malayi microfilariae of single dose FBZ ASD formulation (2 or 40 mg/kg) was also evaluated and compared against the standard microfilaricide, ivermectin (IVM). Systemic exposures of FBZ/FBZ metabolites achieved following dosing were measured by pharmacokinetic (PK) bioanalysis. At necropsy, five weeks following start of FBZ SC injections, there were significant reductions in burdens of motile O. ochengi worms following multiple injections (93%) or single injection (82%). Further, significant proportions of mice dosed following multiple injections (5/6; 83%) or single injection (6/10; 60%) were infection negative (drug-cured). In comparison, no significant reduction in recovery of motile adult O. ochengi adult worms was obtained in any multiple-oral dosage group. Single oral-dosed FBZ did not mediate any significant microfilaricidal activity against circulating B. malayi mf at 2 or 7 days compared with >80% efficacy of single dose IVM. In conclusion, multiple oral FBZ formulation doses, whilst achieving substantial bioavailability, do not emulate the efficacy delivered by the parenteral route in vivo against adult O. ochengi. PK analysis determined FBZ efficacy was related to sustained systemic drug levels rather than achievable Cmax. PK modelling predicted that oral FBZ would have to be given at low dose for up to 5 weeks in the mouse model to achieve a matching efficacious exposure profile.
first_indexed 2024-03-06T23:59:07Z
format Journal article
id oxford-uuid:7550494b-1494-4a90-ab04-55b018e1d804
institution University of Oxford
language English
last_indexed 2024-03-06T23:59:07Z
publishDate 2019
publisher Public Library of Science
record_format dspace
spelling oxford-uuid:7550494b-1494-4a90-ab04-55b018e1d8042022-03-26T20:08:34ZShort-course, oral flubendazole does not mediate significant efficacy against Onchocerca adult male worms or Brugia microfilariae in murine infection modelsJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:7550494b-1494-4a90-ab04-55b018e1d804EnglishSymplectic Elements at OxfordPublic Library of Science2019Sjoberg, HTPionnier, NAljayyoussi, GMetuge, HMNjouendou, AJChunda, VCFombad, FFTayong, DBGandjui, NVTAkumtoh, DNChounna, PWNNdzeshang, BLLachaud, STekle, FQuirynen, LEngelen, MBaeten, BSteven, AWard, SATaylor, MJWanji, STurner, JDThe Onchocerca ochengi adult implant and Brugia malayi microfilariemic Severe-Combined Immunodeficient (SCID) mouse models are validated screens to measure macrofilaricidal and microfilaricidal activities of candidate onchocerciasis drugs. The purpose of this study was to assess whether 5 daily sub-cutaneous (s.c.) injections of standard flubendazole (FBZ) suspension (10mg/kg), a single s.c. injection (10mg/kg) or 5 daily repeated oral doses of FBZ amorphous solid dispersion (ASD) formulation (0.2, 1.5 or 15mg/kg) mediated macrofilaricidal efficacy against O. ochengi male worms implanted into SCID mice. The direct microfilaricidal activity against circulating B. malayi microfilariae of single dose FBZ ASD formulation (2 or 40 mg/kg) was also evaluated and compared against the standard microfilaricide, ivermectin (IVM). Systemic exposures of FBZ/FBZ metabolites achieved following dosing were measured by pharmacokinetic (PK) bioanalysis. At necropsy, five weeks following start of FBZ SC injections, there were significant reductions in burdens of motile O. ochengi worms following multiple injections (93%) or single injection (82%). Further, significant proportions of mice dosed following multiple injections (5/6; 83%) or single injection (6/10; 60%) were infection negative (drug-cured). In comparison, no significant reduction in recovery of motile adult O. ochengi adult worms was obtained in any multiple-oral dosage group. Single oral-dosed FBZ did not mediate any significant microfilaricidal activity against circulating B. malayi mf at 2 or 7 days compared with >80% efficacy of single dose IVM. In conclusion, multiple oral FBZ formulation doses, whilst achieving substantial bioavailability, do not emulate the efficacy delivered by the parenteral route in vivo against adult O. ochengi. PK analysis determined FBZ efficacy was related to sustained systemic drug levels rather than achievable Cmax. PK modelling predicted that oral FBZ would have to be given at low dose for up to 5 weeks in the mouse model to achieve a matching efficacious exposure profile.
spellingShingle Sjoberg, HT
Pionnier, N
Aljayyoussi, G
Metuge, HM
Njouendou, AJ
Chunda, VC
Fombad, FF
Tayong, DB
Gandjui, NVT
Akumtoh, DN
Chounna, PWN
Ndzeshang, BL
Lachaud, S
Tekle, F
Quirynen, L
Engelen, M
Baeten, B
Steven, A
Ward, SA
Taylor, MJ
Wanji, S
Turner, JD
Short-course, oral flubendazole does not mediate significant efficacy against Onchocerca adult male worms or Brugia microfilariae in murine infection models
title Short-course, oral flubendazole does not mediate significant efficacy against Onchocerca adult male worms or Brugia microfilariae in murine infection models
title_full Short-course, oral flubendazole does not mediate significant efficacy against Onchocerca adult male worms or Brugia microfilariae in murine infection models
title_fullStr Short-course, oral flubendazole does not mediate significant efficacy against Onchocerca adult male worms or Brugia microfilariae in murine infection models
title_full_unstemmed Short-course, oral flubendazole does not mediate significant efficacy against Onchocerca adult male worms or Brugia microfilariae in murine infection models
title_short Short-course, oral flubendazole does not mediate significant efficacy against Onchocerca adult male worms or Brugia microfilariae in murine infection models
title_sort short course oral flubendazole does not mediate significant efficacy against onchocerca adult male worms or brugia microfilariae in murine infection models
work_keys_str_mv AT sjoberght shortcourseoralflubendazoledoesnotmediatesignificantefficacyagainstonchocercaadultmalewormsorbrugiamicrofilariaeinmurineinfectionmodels
AT pionniern shortcourseoralflubendazoledoesnotmediatesignificantefficacyagainstonchocercaadultmalewormsorbrugiamicrofilariaeinmurineinfectionmodels
AT aljayyoussig shortcourseoralflubendazoledoesnotmediatesignificantefficacyagainstonchocercaadultmalewormsorbrugiamicrofilariaeinmurineinfectionmodels
AT metugehm shortcourseoralflubendazoledoesnotmediatesignificantefficacyagainstonchocercaadultmalewormsorbrugiamicrofilariaeinmurineinfectionmodels
AT njouendouaj shortcourseoralflubendazoledoesnotmediatesignificantefficacyagainstonchocercaadultmalewormsorbrugiamicrofilariaeinmurineinfectionmodels
AT chundavc shortcourseoralflubendazoledoesnotmediatesignificantefficacyagainstonchocercaadultmalewormsorbrugiamicrofilariaeinmurineinfectionmodels
AT fombadff shortcourseoralflubendazoledoesnotmediatesignificantefficacyagainstonchocercaadultmalewormsorbrugiamicrofilariaeinmurineinfectionmodels
AT tayongdb shortcourseoralflubendazoledoesnotmediatesignificantefficacyagainstonchocercaadultmalewormsorbrugiamicrofilariaeinmurineinfectionmodels
AT gandjuinvt shortcourseoralflubendazoledoesnotmediatesignificantefficacyagainstonchocercaadultmalewormsorbrugiamicrofilariaeinmurineinfectionmodels
AT akumtohdn shortcourseoralflubendazoledoesnotmediatesignificantefficacyagainstonchocercaadultmalewormsorbrugiamicrofilariaeinmurineinfectionmodels
AT chounnapwn shortcourseoralflubendazoledoesnotmediatesignificantefficacyagainstonchocercaadultmalewormsorbrugiamicrofilariaeinmurineinfectionmodels
AT ndzeshangbl shortcourseoralflubendazoledoesnotmediatesignificantefficacyagainstonchocercaadultmalewormsorbrugiamicrofilariaeinmurineinfectionmodels
AT lachauds shortcourseoralflubendazoledoesnotmediatesignificantefficacyagainstonchocercaadultmalewormsorbrugiamicrofilariaeinmurineinfectionmodels
AT teklef shortcourseoralflubendazoledoesnotmediatesignificantefficacyagainstonchocercaadultmalewormsorbrugiamicrofilariaeinmurineinfectionmodels
AT quirynenl shortcourseoralflubendazoledoesnotmediatesignificantefficacyagainstonchocercaadultmalewormsorbrugiamicrofilariaeinmurineinfectionmodels
AT engelenm shortcourseoralflubendazoledoesnotmediatesignificantefficacyagainstonchocercaadultmalewormsorbrugiamicrofilariaeinmurineinfectionmodels
AT baetenb shortcourseoralflubendazoledoesnotmediatesignificantefficacyagainstonchocercaadultmalewormsorbrugiamicrofilariaeinmurineinfectionmodels
AT stevena shortcourseoralflubendazoledoesnotmediatesignificantefficacyagainstonchocercaadultmalewormsorbrugiamicrofilariaeinmurineinfectionmodels
AT wardsa shortcourseoralflubendazoledoesnotmediatesignificantefficacyagainstonchocercaadultmalewormsorbrugiamicrofilariaeinmurineinfectionmodels
AT taylormj shortcourseoralflubendazoledoesnotmediatesignificantefficacyagainstonchocercaadultmalewormsorbrugiamicrofilariaeinmurineinfectionmodels
AT wanjis shortcourseoralflubendazoledoesnotmediatesignificantefficacyagainstonchocercaadultmalewormsorbrugiamicrofilariaeinmurineinfectionmodels
AT turnerjd shortcourseoralflubendazoledoesnotmediatesignificantefficacyagainstonchocercaadultmalewormsorbrugiamicrofilariaeinmurineinfectionmodels